Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanislas Pol

Showing results (171-180 of 441) with videos related to

Pageof 45
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 5, 2002
Severe evolution of chronic hepatitis C in renal transplantation: a case control studyHervé Zylberberg, Bertrand Nalpas, Françoise Carnot, et al.
Transplantation|August 24, 2006
Mycophenolate sodium-induced hepatotoxicity: first reportAlexandre Loupy, Dany Anglicheau, Marie-France Mamzer-Bruneel, et al.
Emerging Infectious Diseases|May 22, 2012
Hepatitis e virus infection in sheltered homeless persons, franceSylvie Larrat, Stéphanie Gaillard, Monique Baccard, et al.
Journal of Hepatology|February 15, 2003
The expression of hepatitis B spliced protein (HBSP) encoded by a spliced hepatitis B virus RNA is associated with viral replication and liver fibrosisPatrick Soussan, Rosella Tuveri, Bertrand Nalpas, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 27, 2007
Early virologic failure in HIV-coinfected hepatitis C patients treated with the peginterferon-ribavirin combination: does abacavir play a role?Firouzé Bani-Sadr, Lise Denoeud, Patrice Morand, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 24, 2008
Erratum to 'The management of chronic hepatitis B in the immunocompromised patient: recommendations from a single topic meeting' [J. Clin. Virol. 41 (4) 2008 243-254]Stephen Barclay, Stanislas Pol, David Mutimer, et al.
Gut|September 21, 2011
Impact of hepatitis C triple therapy availability upon the number of patients to be treated and associated costs in France: a model-based analysisSylvie Deuffic-Burban, Philippe Mathurin, Stanislas Pol, et al.
Journal of Clinical Pharmacology|October 28, 2010
Efficacy and pharmacokinetics of adefovir dipivoxil liquid suspension in patients with chronic hepatitis B and renal impairmentMitchell L Shiffman, Stanislas Pol, Lionel Rostaing, et al.
Gastroenterologie Clinique Et Biologique|January 2, 2008
Risks factors of liver fibrosis in a cohort of intravenous drug users coinfected with HIV and HCV in the HAART era: the role of mixed steatosisFanny Lanternier, Dominique Roulot, Michele Bentata, et al.
Gut|March 17, 2007
Rapid and early virological response to chronic hepatitis C treatment with IFN alpha2b or PEG-IFN alpha2b plus ribavirin in HIV/HCV co-infected patientsChristopher Payan, Adeline Pivert, Patrice Morand, et al.
Pageof 45

Showing results (171-180 of 441) with videos related to

Sort By:
Pageof 45
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 5, 2002
Severe evolution of chronic hepatitis C in renal transplantation: a case control studyHervé Zylberberg, Bertrand Nalpas, Françoise Carnot, et al.
Transplantation|August 24, 2006
Mycophenolate sodium-induced hepatotoxicity: first reportAlexandre Loupy, Dany Anglicheau, Marie-France Mamzer-Bruneel, et al.
Emerging Infectious Diseases|May 22, 2012
Hepatitis e virus infection in sheltered homeless persons, franceSylvie Larrat, Stéphanie Gaillard, Monique Baccard, et al.
Journal of Hepatology|February 15, 2003
The expression of hepatitis B spliced protein (HBSP) encoded by a spliced hepatitis B virus RNA is associated with viral replication and liver fibrosisPatrick Soussan, Rosella Tuveri, Bertrand Nalpas, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 27, 2007
Early virologic failure in HIV-coinfected hepatitis C patients treated with the peginterferon-ribavirin combination: does abacavir play a role?Firouzé Bani-Sadr, Lise Denoeud, Patrice Morand, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 24, 2008
Erratum to 'The management of chronic hepatitis B in the immunocompromised patient: recommendations from a single topic meeting' [J. Clin. Virol. 41 (4) 2008 243-254]Stephen Barclay, Stanislas Pol, David Mutimer, et al.
Gut|September 21, 2011
Impact of hepatitis C triple therapy availability upon the number of patients to be treated and associated costs in France: a model-based analysisSylvie Deuffic-Burban, Philippe Mathurin, Stanislas Pol, et al.
Journal of Clinical Pharmacology|October 28, 2010
Efficacy and pharmacokinetics of adefovir dipivoxil liquid suspension in patients with chronic hepatitis B and renal impairmentMitchell L Shiffman, Stanislas Pol, Lionel Rostaing, et al.
Gastroenterologie Clinique Et Biologique|January 2, 2008
Risks factors of liver fibrosis in a cohort of intravenous drug users coinfected with HIV and HCV in the HAART era: the role of mixed steatosisFanny Lanternier, Dominique Roulot, Michele Bentata, et al.
Gut|March 17, 2007
Rapid and early virological response to chronic hepatitis C treatment with IFN alpha2b or PEG-IFN alpha2b plus ribavirin in HIV/HCV co-infected patientsChristopher Payan, Adeline Pivert, Patrice Morand, et al.
Pageof 45